calendar
5 catalysts · 2 phase 2 completion · 1 phase 1 completion · 1 phase 2 initiation · 1 phase 2 results
next 91 dayslessmore
MonWedFri
5 catalysts · 2 phase 2 completion · 1 phase 1 completion · 1 phase 2 initiation · 1 phase 2 results
Therapy area: Oncology. Indication: Advanced Malignancy, Diffuse Large B-Cell Lymphoma, Head And Neck Squamous Cell Carcinoma (HNSC), Hodgkin Lymphoma (B-Cell Hodgkin Lymphoma), Lymphoma, Melanoma, Non-Small Cell Lung Cancer, Peripheral T-Cell Lymphomas (PTCL), Solid Tumor
Therapy area: Oncology. Indication: Esophageal Cancer, Esophageal Squamous Cell Carcinoma (ESCC)
Therapy area: Oncology. Indication: Multiple Myeloma (Kahler Disease)
Therapy area: Oncology. Indication: Advanced Malignancy, Solid Tumor
Therapy area: Oncology. Indication: Diffuse Large B-Cell Lymphoma, Primary Mediastinal B-Cell Lymphoma